Quercetin Nanoemulsion Ameliorates Neuronal Dysfunction in Experimental Alzheimer's Disease Model

被引:18
|
作者
Alaqeel, Nouf K. [1 ]
AlSheikh, Mona H. [2 ]
Al-Hariri, Mohammed T. [2 ]
机构
[1] Imam Abdulrahman Bin Faisal Univ, Coll Sci, Dept Biol, Dammam 34212, Saudi Arabia
[2] Imam Abdulrahman Bin Faisal Univ, Coll Med, Dept Physiol, Dammam 34719, Saudi Arabia
关键词
quercetin; nanoemulsion; Alzheimer's disease; rats; immunohistochemistry; oxidative; OXIDATIVE STRESS; ALUMINUM-CHLORIDE; ANTIOXIDANT; NANOPARTICLES; CYCLOOXYGENASE; NEUROTOXICITY; ABSORPTION; MECHANISMS; FLAVONOIDS; EXTRACTS;
D O I
10.3390/antiox11101986
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aluminum is the most abundant metal that can get admission to the human through several means that include our food, drinking water, cans, drugs, and deodorants, causing neurodegenerative diseases such as Alzheimer's disease (AD). The present study aims to evaluate the role of quercetin nanoemulsion (QCNE) in attenuating neuronal dysfunction in aluminum chloride (AlCl3)-induced experimental AD. All animals were classified into six groups including negative control group (I): received a vehicle; QC group: received intraperitoneal (IP) injection of QC; Alzheimer's group: received AlCl3 orally; treated group (I): received AlCl3 orally and IP injection of QC; treated group (II): received AlCl3 orally and QC orally; and treated group (III): received AlCl3 orally and IP injection of QCNE. At the end of the experimental period (30 days), the brain was used to study biochemical parameters (measurement of neurotransmitters (serotonin, dopamine, and norepinephrine), oxidant/antioxidant parameters (reduced glutathione, malondialdehyde, superoxide dismutase, and advanced oxidation protein product), and inflammatory markers (adiponectin, interleukin 1 beta, and plasma tumor necrosis factor-alpha)), while another part was for brain immune-histochemical analysis (study cyclooxygenases (COX-1 and COX-2)). Results showed that the mean value of oxidative stress markers was significantly increased in the AD group as well as the inflammatory biomarkers and all the study neurotransmitters, whereas these parameters were attenuated in treated groups, especially those that received QCNE. The immunohistochemistry findings confirm our results. Both approaches (QC and QCNE) succeeded in retracting the negative impact of AlCl3. Meanwhile, the effect of QCNE is more potent in mitigating the impact mediated by AlCl3 in treated animals. In conclusion, the treatment mainly by QCNE has huge potential in protecting against AlCl3-induced neuronal dysfunction, as shown in our results by the elevation of brain antioxidant/anti-inflammatory activities and neurotransmitter levels as well as mending of the histopathological changes in animal models.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Neuronal circuit dysfunction in Alzheimer's disease
    Konnerth, A.
    [J]. FEBS JOURNAL, 2014, 281 : 4 - 4
  • [2] Mitochondrial dysfunction and neuronal apoptosis in Alzheimer's disease
    Takuma, Kazuhiro
    Fukuzaki, Emiko
    Nagai, Taku
    Mizoguchi, Hiroyuki
    Stern, David M.
    Yan, Shirley ShiDu
    Yamada, Kiyofumi
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 45P - 45P
  • [3] Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction
    Sachdeva, Anand Kamal
    Kuhad, Anurag
    Chopra, Kanwaljit
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 127 : 101 - 110
  • [4] The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice
    Maria Sabogal-Guaqueta, Angelica
    Ignacio Munoz-Manco, Juan
    Ramirez-Pineda, Jose R.
    Lamprea-Rodriguez, Marisol
    Osorio, Edison
    Patricia Cardona-Gomez, Gloria
    [J]. NEUROPHARMACOLOGY, 2015, 93 : 134 - 145
  • [5] Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease
    Nobili, Annalisa
    Latagliata, Emanuele Claudio
    Viscomi, Maria Teresa
    Cavallucci, Virve
    Cutuli, Debora
    Giacovazzo, Giacomo
    Krashia, Paraskevi
    Rizzo, Francesca Romana
    Marino, Ramona
    Federici, Mauro
    De Bartolo, Paola
    Aversa, Daniela
    Dell'Acqua, Maria Concetta
    Cordella, Alberto
    Sancandi, Marco
    Keller, Flavio
    Petrosini, Laura
    Puglisi-Allegra, Stefano
    Mercuri, Nicola Biagio
    Coccurello, Roberto
    Berretta, Nicola
    D'Amelio, Marcello
    [J]. NATURE COMMUNICATIONS, 2017, 8
  • [6] Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer’s disease
    Annalisa Nobili
    Emanuele Claudio Latagliata
    Maria Teresa Viscomi
    Virve Cavallucci
    Debora Cutuli
    Giacomo Giacovazzo
    Paraskevi Krashia
    Francesca Romana Rizzo
    Ramona Marino
    Mauro Federici
    Paola De Bartolo
    Daniela Aversa
    Maria Concetta Dell’Acqua
    Alberto Cordella
    Marco Sancandi
    Flavio Keller
    Laura Petrosini
    Stefano Puglisi-Allegra
    Nicola Biagio Mercuri
    Roberto Coccurello
    Nicola Berretta
    Marcello D’Amelio
    [J]. Nature Communications, 8
  • [7] Neuronal Calcium Signaling, Mitochondrial Dysfunction, and Alzheimer's Disease
    Supnet, Charlene
    Bezprozvanny, Ilya
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 : S487 - S498
  • [8] The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
    Nibaldo C Inestrosa
    Enrique M Toledo
    [J]. Molecular Neurodegeneration, 3
  • [9] The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease
    Inestrosa, Nibaldo C.
    Toledo, Enrique M.
    [J]. MOLECULAR NEURODEGENERATION, 2008, 3 (1)
  • [10] Evidence of increased neuronal dysfunction in Alzheimer's disease with psychosis
    Sweet, RA
    Klunk, WE
    Pettegrew, JW
    Hamilton, RL
    Lopez, OL
    Wisniewski, SR
    DeKosky, ST
    [J]. BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 143S - 143S